RTW INVESTMENTS, LP
Q2 2021 13F-HR Holdings
Net value change ($000)
+221,275
(3.5%)
New positions
14
Sold out positions
11
Turnover %
10.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Dicerna Pharmaceuticals Inc | 89,880 | 47.1% |
| EPIX | 79,009 | 958.7% |
| PTGX | 66,571 | 73.3% |
| MASI | 63,677 | 46.6% |
| ESTA | 57,538 | 39.7% |
| RGNX | 54,079 | 380.6% |
| SPY | 51,428 | 13.7% |
| CLDX | 50,191 | 62.3% |
| ALNY | 47,690 | 20.1% |
| ILMN | 43,362 | 23.4% |
Top Reduces (Value $000, Stocks/ETFs)
| CERNER Corp | -127,550 | -100.0% |
| ARVN | -107,267 | -100.0% |
| IMVT | -101,962 | -100.0% |
| Translate Bio, Inc. | -72,262 | -100.0% |
| iTeos Therapeutics, Inc. | -50,402 | -53.4% |
| ADVM | -46,708 | -64.5% |
| CRIS | -40,973 | -100.0% |
| RCKT | -33,367 | -4.8% |
| KURA | -30,586 | -100.0% |
| LONA | -29,284 | -60.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|